³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, Á¦Ç°º°, Áø´Üº°, Ä¡·áº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)
Brain Tumor Diagnosis and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type, Product, Diagnosis, Therapeutics, End Use, and Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1762266
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 115 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,900,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,288,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,676,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 65¾ï 972¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀåÀº ³úÀÇ Á¾¾ç ¼ºÀåÀ» ½Äº°Çϰí Ä¡·áÇϱâ À§ÇÑ ÀÇ·á ±â¼ú ¹× ÀÇÇÐÀû °³ÀÔÀÇ °³¹ß ¹× °³¹ßÀ» Áß½ÉÀ¸·Î ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ¾ç¼ººÎÅÍ ¾Ç¼º±îÁö ´Ù¾çÇÑ ³úÁ¾¾çÀ¸·Î ÀÎÇÑ º¹ÀâÇÑ Áø´Ü ¹× Ä¡·á ¹®Á¦¸¦ ÇØ°áÇØ¾ß ÇÏ´Â Çʿ伺ÀÔ´Ï´Ù. ȯÀÚÀÇ ¿¹ÈÄ¿Í »îÀÇ ÁúÀ» °³¼±Çϱâ À§Çؼ­´Â ÷´Ü ¿µ»ó Áø´Ü ±â¼ú, Á¤±³ÇÑ ÀÓ»ó °Ë»ç Áø´Ü, Çõ½ÅÀûÀÎ Ä¡·á¹ýÀ» ÅëÇÕÇÑ ´Ù°¢ÀûÀÎ Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ½Å°æ ¿µ»ó Áø´Ü Àåºñ, ºÐÀÚÁø´Ü µµ±¸, ¼ö¼ú Àåºñ, ¹æ»ç¼± Ä¡·á ½Ã½ºÅÛ, ¾à¹° Ä¡·á µî ȯÀÚ¿Í ÀÇ·áÁøÀÇ ´Ù¾çÇÑ ¿ä±¸¸¦ ¹Ý¿µÇÏ´Â ´Ù¾çÇÑ Á¦Ç°°ú ¼­ºñ½º°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀ» ºÐ¼®ÇÏ¸é ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú ÁøÈ­ÇÏ´Â Ä¡·á ÆÐ·¯´ÙÀÓÀÌ Æ¯Â¡ÀÎ »óȲÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù. ³úÁ¾¾ç À¯º´·üÀÇ Áõ°¡´Â ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í ÇÔ²² Å« ½ÃÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸°³¹ßÀº Áø´Ü Á¤È®µµ Çâ»ó, Ç¥Àû Ä¡·áÁ¦ °³¹ß, ȯÀÚ »ýÁ¸À² Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ ¹× ´Ü¹éÁúüÇÐÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ýÀÇ Ã¤ÅÃÀº Ä¡·á Àü·«¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿µ»ó Áø´Ü ¹× µ¥ÀÌÅÍ ºÐ¼®¿¡ ÀΰøÁö´É°ú ¸Ó½Å·¯´×À» ÅëÇÕÇÏ¿© ÀÓ»óÀû ÀÇ»ç°áÁ¤ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀåÀº ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇϱâ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ ²÷ÀÓ¾ø´Â Ãß±¸·Î Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

À¯Çüº°·Î´Â ½Å°æ±³Á¾À̳ª ¼ö¸·Á¾°ú °°Àº Á¾¾çÀÇ ¹ß»ý·üÀÌ ³ô°í ±¤¹üÀ§ÇÑ Áø´Ü ¹× Ä¡·á °³ÀÔÀÌ ÇÊ¿äÇÑ ÀÏÂ÷ ¼¼ºÐÈ­°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

Á¦Ç°º°·Î´Â ³úÁ¾¾ç Áø´Ü ¹× ºÐ·ù¿¡ ÇʼöÀûÀÎ Á¶Á÷ÇÐÀû ¹× ¸é¿ªÁ¶Á÷È­ÇÐÀû ÀýÂ÷¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ½ºÅ×ÀÎ ¹× ¹Ù´Ï½Ã ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

Áø´Üº°·Î´Â MRI ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ºñħ½ÀÀû Ư¼º°ú ¶Ù¾î³­ °íÇØ»óµµ ¿µ»ó ó¸® ´É·ÂÀ¸·Î ÀÎÇØ Á¾¾çÀÇ Á¤È®ÇÑ À§Ä¡ ÆÄ¾Ç ¹× Ư¼ºÈ­¿¡ ÇʼöÀûÀÔ´Ï´Ù.

Ä¡·áº°·Î´Â ¼ö¼úÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» À¯ÁöÇϰí Àִµ¥, ÀÌ´Â Á¾¾ç ÀýÁ¦¼úÀÇ ±âº» ¿ªÇÒ, ƯÈ÷ Á¢±ÙÀÌ ¿ëÀÌÇÏ°í °æ°è°¡ ¸íÈ®ÇÑ Á¾¾ç¿¡ ´ëÇÑ ±âº»ÀûÀÎ °³ÀÔ Àü·«¿¡ ±âÀÎÇÕ´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â º´¿øÀÌ Á¾ÇÕÀûÀÎ Áø·á¸¦ Á¦°øÇϰí ÇÑ ÁöºØ ¾Æ·¡¿¡¼­ ´Ù¾çÇÑ Áø´Ü ¹× Ä¡·á ¼­ºñ½º¸¦ Æ÷°ýÇϰí Àֱ⠶§¹®¿¡ ÀÏÂ÷ Áø·áÀÇ Á¦°øÀÚ°¡ µÇ±â ¶§¹®ÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¼¼°è ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí Àִµ¥, ÀÌ´Â ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í ³úÁ¾¾ç À¯º´·üÀÌ ³ô±â ¶§¹®ÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, ³úÁ¾¾ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇØ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸À̰í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Hoffmann-La Roche AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bristol Myers Squibb Company, Siemens Healthineers AG, GE Healthcare (General Electric Company), Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Intuitive Surgical, Inc., Hitachi, Ltd. µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå : Á¦Ç°º°

Á¦7Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå : Áø´Üº°

Á¦8Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå : Ä¡·áº°

Á¦9Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦10Àå ¼¼°èÀÇ ³úÁ¾¾ç Áø´Ü ¹× Ä¡·á ½ÃÀå : Áö¿ªº°

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global brain tumor diagnosis and therapeutics market size is expected to reach USD 6,509.72 million by 2034, according to a new study by Polaris Market Research. The report "Brain Tumor Diagnosis and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Primary and Secondary), Product, Diagnosis, Therapeutics, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The brain tumor diagnosis and therapeutics market centers on the development and deployment of medical technologies and pharmaceutical interventions aimed at the identification and treatment of neoplastic growths within the brain. This market is driven by the imperative to address the complex diagnostic and therapeutic challenges posed by brain tumors, which range from benign to highly malignant. It involves a multifaceted approach, integrating advanced imaging techniques, sophisticated laboratory diagnostics, and innovative treatment modalities to improve patient outcomes and quality of life. The market encompasses a broad spectrum of products and services, including neuroimaging equipment, molecular diagnostic tools, surgical devices, radiation therapy systems, and pharmaceutical therapies, reflecting the diverse needs of patients and healthcare providers.

An analysis of this market reveals a landscape characterized by rapid technological advancements and evolving treatment paradigms. The increasing prevalence of brain tumors, coupled with the growing geriatric population, is a significant market driver. Ongoing research and development efforts are focused on enhancing diagnostic accuracy, developing targeted therapies, and improving patient survival rates. The adoption of personalized medicine approaches, driven by advancements in genomics and proteomics, is transforming treatment strategies. Furthermore, the integration of artificial intelligence and machine learning in diagnostic imaging and data analysis is enhancing the efficiency and precision of clinical decision-making. The brain tumor diagnosis and therapeutics market is poised for continued growth, driven by the relentless pursuit of innovative solutions to combat these challenging diseases.

Brain Tumor Diagnosis and Therapeutics Market Report Highlights

By type, the primary segment holds the largest market share, driven by the higher incidence of tumors like gliomas and meningiomas, necessitating extensive diagnostic and therapeutic interventions.

By product, the stains & varnishes segment commands the largest market share due to its essential role in histological and immunohistochemical procedures critical for brain tumor diagnosis and classification.

Based on diagnosis, the MRI segment leads the market, attributed to its non-invasive nature and superior high-resolution imaging capabilities, crucial for precise tumor localization and characterization.

By therapeutics, the surgery segment maintains the largest market share, owing to its fundamental role in tumor removal, particularly for accessible and well-defined tumors, which remains a primary intervention strategy.

Based on end use, the hospitals segment holds the largest market share, driven by their comprehensive care offerings, encompassing a wide range of diagnostic and therapeutic services under one roof, making them primary care providers.

By region, North America holds the largest share of the global market owing to its well-established healthcare infrastructure and high prevalence of brain tumors. Asia Pacific is experiencing the highest growth rate due to the increasing geriatric population, rising awareness of brain tumors, and improving healthcare access.

Key players operating within the market include Hoffmann-La Roche AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bristol Myers Squibb Company, Siemens Healthineers AG, GE Healthcare (General Electric Company), Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Intuitive Surgical, Inc., and Hitachi, Ltd.

Polaris Market Research has segmented the brain tumor diagnosis and therapeutics market report on the basis of type, product, diagnosis, therapeutics, end use, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Primary

Secondary

By Product Outlook (Revenue - USD Million, 2020-2034)

Stains & Varnishes

Shellacs

Lacquers

Others

By Diagnosis Outlook (Revenue - USD Million, 2020-2034)

MRI

CT Scan

Tissue Sampling

PET-CT scan

Cerebral Arteriogram

Lumbar Puncture

Molecular Testing

EEG

Others

By Therapeutics Outlook (Revenue - USD Million, 2020-2034)

Surgery

Radiation Therapy

Chemotherapy

Immunotherapy

Targeted Therapy

Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Oncology Treatment Centers

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Brain Tumor Diagnosis and Therapeutics Market Insights

5. Global Brain Tumor Diagnosis and Therapeutics Market, by Type

6. Global Brain Tumor Diagnosis and Therapeutics Market, by Product

7. Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis

8. Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics

9. Global Brain Tumor Diagnosis and Therapeutics Market, by End Use

10. Global Brain Tumor Diagnosis and Therapeutics Market, by Geography

11. Competitive Landscape

12. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â